- Home
- RS vs WST Comparison
RS vs WST Comparison
Compare RS & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RS
- WST
- Stock Information
- Founded
- RS 1939
- WST 1923
- Country
- RS United States
- WST United States
- Employees
- RS N/A
- WST N/A
- Industry
- RS Metal Fabrications
- WST Medical/Dental Instruments
- Sector
- RS Industrials
- WST Health Care
- Exchange
- RS Nasdaq
- WST Nasdaq
- Market Cap
- RS 14.4B
- WST 15.2B
- IPO Year
- RS 1994
- WST N/A
- Fundamental
- Price
- RS $299.96
- WST $206.64
- Analyst Decision
- RS Hold
- WST Strong Buy
- Analyst Count
- RS 4
- WST 6
- Target Price
- RS $332.67
- WST $349.00
- AVG Volume (30 Days)
- RS 269.8K
- WST 957.3K
- Earning Date
- RS 04-23-2025
- WST 04-24-2025
- Dividend Yield
- RS 1.60%
- WST 0.41%
- EPS Growth
- RS N/A
- WST N/A
- EPS
- RS 14.01
- WST 6.37
- Revenue
- RS $13,674,900,000.00
- WST $2,895,800,000.00
- Revenue This Year
- RS $4.80
- WST $1.24
- Revenue Next Year
- RS $4.71
- WST $6.56
- P/E Ratio
- RS $21.46
- WST $32.43
- Revenue Growth
- RS N/A
- WST N/A
- 52 Week Low
- RS $250.07
- WST $187.43
- 52 Week High
- RS $326.87
- WST $372.79
- Technical
- Relative Strength Index (RSI)
- RS 61.56
- WST 43.32
- Support Level
- RS $292.14
- WST $212.87
- Resistance Level
- RS $306.53
- WST $220.94
- Average True Range (ATR)
- RS 5.62
- WST 5.73
- MACD
- RS 1.22
- WST 0.81
- Stochastic Oscillator
- RS 74.58
- WST 11.12
About RS Reliance Steel & Aluminum Co. (DE)
Reliance Inc is a diversified metal solutions provider and metals service center company. It provides value-added metals processing services and distributes.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.